Phosphodiesterase-5 inhibitors as novel cardioprotective agents: have we reached threshold for large-scale clinical trials? | Heart

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BCS

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

PostScript

Correspondence

Phosphodiesterase-5 inhibitors as novel cardioprotective agents: have we reached threshold for large-scale clinical trials?

Online download statistics by month:

Online download statistics by month: October 2017 to July 2022

	Abstract	Full	Pdf
Oct 2017	820	45	25
Nov 2017	94	10	7
Dec 2017	65	10	4
Jan 2018	57	9	4
Feb 2018	76	4	3
Mar 2018	44	5	5
Apr 2018	28	0	1
May 2018	36	4	0
Jun 2018	40	2	1
Jul 2018	59	5	3
Aug 2018	43	4	1
Sep 2018	33	0	0
Oct 2018	25	0	0
Nov 2018	42	2	1
Dec 2018	31	0	0
Jan 2019	53	1	0
Feb 2019	12	2	1
Mar 2019	22	4	1
Apr 2019	12	0	0
May 2019	21	2	0
Jun 2019	18	2	0
Jul 2019	20	2	0
Aug 2019	18	0	0
Sep 2019	16	0	0
Oct 2019	37	1	0
Nov 2019	49	2	1
Dec 2019	20	0	0
Jan 2020	19	4	1
Feb 2020	23	0	0
Mar 2020	6	4	1
Apr 2020	7	0	0
May 2020	20	0	0
Jun 2020	12	0	0
Jul 2020	20	1	0
Aug 2020	9	1	0
Sep 2020	14	0	0
Oct 2020	33	0	0
Nov 2020	10	0	0
Dec 2020	21	0	0
Jan 2021	10	0	0
Feb 2021	26	0	0
Mar 2021	15	1	1
Apr 2021	15	1	1
May 2021	25	0	0
Jun 2021	2	1	0
Jul 2021	2	0	0
Aug 2021	1	0	0
Sep 2021	3	3	2
Oct 2021	19	0	0
Nov 2021	23	0	0
Dec 2021	16	3	0
Jan 2022	24	3	0
Feb 2022	30	0	0
Mar 2022	16	0	0
Apr 2022	16	1	0
May 2022	43	2	0
Jun 2022	23	4	0
Jul 2022	10	0	0
Total	2304	145	64